Why 23andMe Stock Was Up More Than 9% on Tuesday

Why 23andMe Stock Was Up More Than 9% on Tuesday
·2 min read

Investors may see potential in the company's proposed acquisition of telehealth company Lemonaid.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting